UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 24, 2022 4:00 P.M.
Form:
S-3
CIK:
0001445499
Company Name:
IMPEL PHARMACEUTICALS INC
File Number:
333-264987